Alexion Pharm Inc
(ALXN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 04-2003 | 01-2003 | 10-2002 | 07-2002 | 04-2002 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 61,208 | 52,301 | 20,204 | 47,574 | 121,427 |
| Marketable Securities | 169,727 | 200,882 | 263,254 | 261,010 | 203,750 |
| Receivables | N/A | N/A | N/A | N/A | 700 |
| Other current assets | 1,393 | 389 | 297 | 863 | 469 |
| TOTAL | $234,734 | $255,544 | $286,081 | $310,784 | $327,139 |
| Non-Current Assets | |||||
| PPE Net | 11,903 | 14,736 | 15,110 | 14,874 | 13,736 |
| Intangibles | 19,954 | 19,954 | 19,954 | 19,954 | 20,165 |
| Other Non-Current Assets | 15,452 | 15,603 | 8,558 | 8,457 | 9,120 |
| TOTAL | $47,309 | $50,293 | $43,622 | $43,285 | $43,021 |
| Total Assets | $282,043 | $305,837 | $329,703 | $354,069 | $370,160 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,246 | 6,289 | 8,262 | 9,843 | 8,032 |
| Accrued Expenses | 5,981 | 5,637 | 5,747 | 6,930 | 5,239 |
| TOTAL | $8,816 | $12,515 | $14,555 | $17,319 | $13,860 |
| Non-Current Liabilities | |||||
| Long Term Debt | 3,920 | 3,920 | 3,920 | 3,920 | 3,920 |
| Deferred Revenues | 589 | 589 | 546 | 546 | 589 |
| Other Non-Current Liabilities | 120,000 | 120,000 | 120,000 | 120,000 | 120,000 |
| TOTAL | $130,831 | $130,978 | $131,125 | $131,272 | $131,419 |
| Total Liabilities | $139,647 | $143,493 | $145,680 | $148,591 | $145,279 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 72,853 | 72,835 | 72,821 | N/A | 72,767 |
| Common Shares | 2 | 2 | 2 | 2 | 2 |
| Retained earnings | -243,682 | -223,904 | -202,439 | -180,799 | -159,961 |
| Other shareholders' equity | 1,694 | 1,932 | 2,238 | 2,078 | 738 |
| TOTAL | $142,396 | $162,344 | $184,023 | $205,478 | $224,881 |
| Total Liabilities And Equity | $282,043 | $305,837 | $329,703 | $354,069 | $370,160 |